CD47 and hepatocellular carcinoma: In addition, the same group also suggested that blocking of CD47 and combination with chemotherapeutic drugs enhance macrophage-mediated phagocytosis, which means lower expression of CD47 benefits the treatment with adjuvant transcatheter arterial chemoembolization (TACE) of HCC patients [58].